mRNA acts as marker in Alzheimer’s patients

Through mathematical modeling and collaboration with scientists at the University of California San Francisco (UCSF), McGill researchers, including Rached Alkallas, graduate student in the Department of Human Genetics and the primary author of the seminal study published in Nature Communications, have identified a protein that sharply decreases in patients with[Read More…]

Predicting Alzheimer’s with artificial intelligence

Researchers in the Douglas Mental Health University Institute’s Translational Neuroimaging Laboratory at McGill have created an artificial intelligence-based algorithm to recognize dementia before its onset—an elusive task, even for neurologists. The algorithm uses statistics to learn what the determining markers of the disease are—a process called machine learning, a branch[Read More…]

McGill researchers identify possible treatment for autism-like disorder

Autism Spectrum Disorder (ASD), commonly known simply as Autism, comprises a range of neurodevelopmental disorders, with varying degrees of symptoms such as repetitive behaviors, impaired communications, and poor social engagement. According to the Centers for Disease Control and Prevention, one in every 68 children across the globe, or 70 million people,[Read More…]

What’s the deal with CRISPR?

CRISPR offers the potential to cure presently untreatable cancers and diseases. Moreover, it could revive an extinct organism, such as the mammoth, using tiny bits of genomic information that scientists have collected through their serendipitous discoveries. “CRISPR is a gene editing technique that allows investigators to alter the gene sequence[Read More…]

Read the latest issue

Read the latest issue